Prescribing of tamoxifen by all CCGs

Why it matters: Alongside its use as a cancer treatment, in 2013 NICE recommended that tamoxifen should also be prescribed for chemoprevention of breast cancer for pre-menopausal women at increased risk. Improving the use of preventative therapies was also reiterated in England's Cancer Strategy for 2015-2020. This measure accompanies our paper investigating the national response to these guidelines, published in the British Journal of Cancer.

Description: Number of Average Daily Quantities (ADQs) for tamoxifen (20mg/day) per 1000 female population aged 35-74.


Tagged as: NICE, Mentioned in Papers (or browse all measures)

CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.